WINTER SPRINGS, Fla., Jan. 26, 2023 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 fourth quarter financial results before the market opens on Thursday, February 2, 2023. IRADIMED management will host a conference call...

Reports preliminary fourth quarter 2022 revenue of $14.9 millionAnnounces full-year and first-quarter 2023 financial guidance WINTER SPRINGS, Fla., Jan. 18, 2023 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) today announced selected preliminary financial...

Revenue was $13.4 million and increased by 23%Operating income was $4.1 million and increased 32%GAAP diluted EPS was $0.27 and increased by 35%Announces fourth quarter 2022 financial guidance WINTER SPRINGS, Fla., Nov. 03, 2022 -- IRADIMED CORPORATION (the "Company")...

WINTER SPRINGS, Fla., Oct. 27, 2022 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 third quarter financial results before the market opens on Thursday, November 3rd. IRADIMED management will host a conference call the...

Reports second quarter 2022 revenue of $12.7 million, GAAP diluted EPS of $0.26 and non-GAAP diluted EPS of $0.26Announces third quarter 2022 financial guidance WINTER SPRINGS, Fla., July 29, 2022 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD), announced today...

WINTER SPRINGS, Fla., July 28, 2022 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 second quarter financial results before the market opens on Friday, July 29th. IRADIMED management will host a conference call the same...

WINTER SPRINGS, Fla., July 22, 2022 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 second quarter financial results before the market opens on Friday, July 29th. IRADIMED management will host a conference call the same...

WINTER SPRINGS, Fla., May 26, 2022 -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that John (Jack) Glenn has been appointed Chief Financial Officer effective on or before June 20, 2022. Mr. Glenn will assume responsibility for all areas of accounting and...

Reports first quarter 2022 revenue of $12.3 million, GAAP diluted EPS of $0.20 and non-GAAP diluted EPS of $0.22Announces second quarter 2022 financial guidanceIncreases full-year 2022 financial guidance WINTER SPRINGS, Fla., April 29, 2022 -- IRADIMED CORPORATION...

WINTER SPRINGS, Fla., April 28, 2022 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD), announced today announced that Chris Scott, Chief Financial and Operating Officer, has resigned from the Company effective May 27, 2022. Mr. Scott started at the Company in...